Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection Go to Publication You Might Also Like Prognostic Factors for Adverse Outcomes in COVID-19 Infection September 3, 2020 Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan. December 25, 2017 The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020 Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. January 31, 2009 MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020
Bronchoalveolar lavage contamination by sterile containers: A unique and unrecognized cause of a false-positive galactomannan. December 25, 2017
The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis January 9, 2020
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. January 31, 2009
MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network September 3, 2020